【摘要】 目的:观察胃肠舒治疗糖尿病性胃轻瘫(DGP)的效果。方法:符合纳入标准的DGP患者96例,随机分为两组,分别给予胃肠舒和贝络纳口服,原来的控制血糖方案不变,疗程为4周。观察治疗前后临床症状、空腹和餐后2小时血糖、胃窦十二指肠消化间期移行性复合运动波(MMC)及胃电图(EGG)等变化。结果:两组均能明显改善患者的临床症状,胃肠舒组的显效率为62.50%,总有效率为91.67%;贝络纳组分别为60.42%和89.58%。治疗后两组患者的MMC明显改善,相持续时间、相持续时间和收缩波幅等与治疗前比较差异均有显著性(P<0.05);EGG主频率比增加、主功率比增强,与治疗前比较差异均有显著性(P<0.05或P<0.01)。胃肠舒组还可降低餐后2小时血糖。结论:胃肠舒能明显改善DGP患者的临床症状、MMC及胃电活动,同时又能降低餐后2小时血糖,是治疗DGP的有效方剂。更多还原

【Abstract】 Objective:To observe efficacy of Weichangshu in treatment of diabetic gastroparesis(DGP).Methods:96 cases of DGP conformed with the criteria were randomly divided into two groups.They were treated by oral administration of Weichangshu and Mosapride respectively for 4 weeks in addition to original treatment program for controlling blood sugar.Changes of clinical symptoms,FBG and P2hBG,gastric antrum-duodenum interdigestive period migrating motion compound wave(MMC)and electrogastrogram(EGG)before and after treatment were investigated.Results:Clinical symptoms were significantly improved in both groups.The markedly effective rate was 62.50% and the total effective rate was 91.67% in the Weichangshu group,and the corresponding index was 60.42% and 89.58% in the Mosapride group.After treatment,MMC significantly improved in both groups,with significant differences in lasting time of phase Ⅱ,and phase Ⅲ,and the contraction amplitude as compared with those before treatment(P<0.05).EGG main frequency ratio was increased and the EGG main power ratio was strengthened with significant differences as compared with those before treatment(P<0.05 or P<0.01).P2hBG decreased in the Weichangshu group.Conclusion:Weichangshu can significantly improve clinical symptoms,MMC and electric activity of the stomach,decrease postprandial blood sugar in the patient of DGP.It is an effective prescription for DGP.更多还原